Khasianine(CAS: 32449-98-2)

Khasianine (CAS: 32449-98-2) is classified under the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) as a Category 4 skin sensitiser. In the European Union, it is regulated under REACH, requiring manufacturers and importers to register substances above a certain tonnage. FDA and EPA have not specifically classified Khasianine; however, it may be subject to reporting requirements under the Toxic Substances Control Act (TSCA) if used or manufactured in the United States.

Khasianine (CAS: 32449-98-2) can be synthesized using various analogs and isomers, such as khasianine B or C, which may offer similar biological activity. Common alternative reagents include 2-(2-hydroxyanilino)-1,3,4-thiadiazole and other thiadiazole derivatives. These alternatives can provide similar or enhanced properties for specific applications, depending on the desired end use.

The market for Khasianine (CAS: 32449-98-2) is growing due to its potential as an antifungal and antioxidant agent. Research trends focus on its dermatological applications and its ability to induce cell death in cancer cells. Market demand is driven by increasing consumer interest in natural products with potent biological activities. However, further studies are needed to establish its safety and efficacy for broader commercial use.

Waste containing Khasianine (CAS: 32449-98-2) should be collected in appropriate containers and stored separately to prevent contamination. Properly incinerate the waste in a licensed facility or use professional waste disposal services. Ensure that environmental protection measures are taken, including neutralizing any residual solvents and treating the waste to meet local disposal regulations. Follow all safety and disposal guidelines to protect both human health and the environment.